Efficacy and Tolerability of a New HFA-Propelled Fluticasone/Formoterol Combination Inhaler Compared to Budesonide/Formoterol Combination in Subjects With Moderate to Persistent Asthma

J Gogtay,Akash Balki,Sonia Dalal,Ajeet Singh, Suhas Bardapurkar, Balmurugan Santhanam,Bhanupratap Singh,Rajendra Mehta,Surya Kant,Salil Bhargava, Bharat Trivedi, Animesh Arya,Shrikant Papinwar, Sameer Chandrate,Bhikchand Mutha, Kedarnath Poddar,Abhijit Vaidya, Suhas Talele

Chest（2010）

引用 0|浏览4

暂无评分

摘要

PURPOSE: In patients of bronchial asthma not adequately controlled by inhaled corticosteroids (ICS) alone, the addition of long acting beta agonists is recommended. We evaluated the safety and efficacy of a new HFA propelled pressurized metered dose inhaler (pMDI) containing a combination of Fluticasone and Formoterol compared to the combination of Budesonide/Formoterol.

查看译文

关键词

fluticasone/formoterol combination inhaler,persistent asthma,fluticasone/formoterol combination,budesonide/formoterol,hfa-propelled

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要